Linalool, a Fragrance Compound in Plants, Protects Dopaminergic Neurons and Improves Motor Function and Skeletal Muscle Strength in Experimental Models of Parkinson's Disease

• Published in: International journal of molecular sciences Vol. 25; no. 5; p. 2514
• Main Authors: Chang, Wan-Hsuan, Hsu, Hung-Te, Lin, Chih-Cheng, An, Li-Mei, Lee, Chien-Hsing, Ko, Horng-Huey, Lin, Chih-Lung, Lo, Yi-Ching
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 21.02.2024; MDPI
• Subjects: 1-Methyl-4-phenylpyridinium; Acyclic Monoterpenes; Animals; Antidepressants; antioxidant; Antioxidants; Antioxidants - metabolism; Anxiety; Apoptosis; Brain-derived neurotrophic factor; Cell death; Disease; Dopamine; Dopaminergic Neurons - metabolism; gamma-Aminobutyric Acid - metabolism; Humans; linalool; Mice; Models, Theoretical; motor activity; Muscle Strength; Muscles; Neuroblastoma - metabolism; Neurons; neuroprotection; Neuroprotective Agents - pharmacology; Odorants; Oxidative stress; Parkinson Disease - metabolism; Parkinson’s disease; Protein expression; Proteins; Quality of life; Resveratrol; Sirtuin 1 - metabolism; Tremor; Taiwan; antioxidant; linalool; neuroprotection; Parkinson’s disease; motor activity
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25052514

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the gradual loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc), resulting in reduced dopamine levels in the striatum and eventual onset of motor symptoms. Linalool (3,7-dimethyl-1,6-octadien-3-ol) is a monoterpene in aromatic plants exhibiting antioxidant, antidepressant, and anti-anxiety properties. The objective of this study is to evaluate the neuroprotective impacts of linalool on dopaminergic SH-SY5Y cells, primary mesencephalic and cortical neurons treated with 1-methyl-4-phenylpyridinium ion (MPP ), as well as in PD-like mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Cell viability, α-tubulin staining, western blotting, immunohistochemistry and behavioral experiments were performed. In MPP -treated SH-SY5Y cells, linalool increased cell viability, reduced neurite retraction, enhanced antioxidant defense by downregulation of apoptosis signaling (B-cell lymphoma 2 (Bcl-2), cleaved caspase-3 and poly ADP-ribose polymerase (PARP)) and phagocyte NADPH oxidase (gp91 ), as well as upregulation of neurotrophic signaling (brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF)) and nuclear factor-erythroid 2 related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. In MPP -treated primary mesencephalic neurons, linalool enhanced the expressions of tyrosine hydroxylase (TH), Sirtuin 1 (SirT1), and parkin. In MPP -treated primary cortical neurons, linalool upregulated protein expression of SirT1, γ-Aminobutyric acid type A-α1 (GABA -α1), and γ-Aminobutyric acid type B (GABA ). In PD-like mice, linalool attenuated the loss of dopamine neurons in SNpc. Linalool improved the motor and nonmotor behavioral deficits and muscle strength of PD-like mice. These findings suggest that linalool potentially protects dopaminergic neurons and improves the impairment symptoms of PD.